The global acute care telemedicine market size was estimated at around USD 23.97 billion in 2023 and it is projected to hit around USD 97.23 billion by 2033, growing at a CAGR of 15.03% from 2024 to 2033.
The acute care telemedicine market has witnessed significant growth in recent years, driven by advancements in technology, increasing adoption of telemedicine solutions, and the growing need for efficient healthcare delivery.
The growth of the acute care telemedicine market is propelled by an advancement in technology, particularly in high-definition video conferencing and remote monitoring devices, are driving innovation in telemedicine solutions, enabling healthcare providers to deliver timely and effective care to patients. Secondly, the increasing adoption of telemedicine services across various healthcare settings, including hospitals and specialty clinics, is expanding access to acute care, particularly in underserved rural areas where access to specialty care may be limited. Additionally, the cost savings associated with telemedicine, including reductions in hospital readmissions and transportation costs, are driving healthcare organizations to embrace telemedicine solutions to optimize resource utilization and improve operational efficiency. Lastly, the convenience of virtual consultations and remote monitoring appeals to patients seeking timely medical advice without the need for in-person visits, further driving the growth of the acute care telemedicine market.
The clinician-to-patient segment accounted for the largest revenue share of 64% in 2023. This is owing to the increased adoption of telemedicine solutions by consumers, physicians, and hospitals as patients seek to avoid hospital visits to reduce the chances of exposure to coronavirus. In addition, acute care telemedicine provides access to resources and care for patients in rural areas or areas with a shortage of physicians, improves efficiency and lower medical expense, reduces patient travel, and wait times, and allows for comparable or improved quality of care.
The Clinician-to-clinician segment is expected to witness the fastest CAGR of 15.25% in the forecast period. Clinician-to-clinician acute care telemedicine allows healthcare providers to coordinate with specialists throughout the treatment in emergency cases and real-time patient health monitoring. It provides on-demand access to medical experts in any field to treat abrupt injuries or diseases that can occur in an emergency.
The teleradiology segment dominated the market and held the largest revenue share of 38% in 2023. Teleradiology system determined by technological development has emerged as one of the most consistent modes of patient care method in any given situation. The treatment involves various techniques for capturing internal body images such as ultrasound, X-rays, and MRI scans, to help with diagnosis and further treatment plans. Teleradiology also allows healthcare experts to get a medical image from one location and transfer it to another location where it can be explained by a radiologist for diagnostic purposes.
The telepsychiatry segment is estimated to witness the fastest CAGR of 15.52% in the forecast period. This is owing to the increased awareness among people suffering from various mental health conditions such as eating disorders, anxiety, schizophrenia, substance abuse, and several others. The telepsychiatry sector is witnessing significant growth as it holds the potential to become a better option to traditional in-person psychiatric facilities.
The hospital and clinics segment dominated the market and held the largest revenue share of 77% in 2023 and is expected to continue its dominance in the forecast period. This is owing to the shortage of specialist physicians, especially in developing countries, and increased demand for better healthcare access among the people. Telemedicine solutions are being adopted globally for the triage and treatment of patients, enabling protection for both patients and medical professionals to reduce the risk of exposure.
Virtual options can substantially increase effectiveness compared to in-person physician appointments. Telemedicine also allows the monitoring of patients in emergency cases such as CT assessment of mild traumatic brain injuries. This can assist doctors to decide if the patient needs to admit to a hospital or can be treated locally and allow post-treatment routine checkups. In addition, telehealth provides an at-home interactive audio and video telecommunication system, that allow real-time connection among doctors, nurses, and patients.
North America dominated the market and accounted for the largest revenue share of 44% in 2023. Rapid advancements in the medical sector, allocation of funds for medical research, and developments are some of the key factors contributing to regional market growth. The variety of successful and operational telemedicine and telehealth models and the developed healthcare infrastructure of the region are some of the key factors contributing to the regional market growth. For instance, In March 2020, the U.S. Centers for Medicare & Medicaid Services (CMS) widened access to Medicare telehealth services to provide the beneficiaries with a wider choice of services from their doctors without having to travel to the healthcare facility.
In Europe, the acute care telemedicine market is anticipated to witness rapid growth in the forecast period with a CAGR of 15.29%. The increasing elderly population and the development and deployment of medical technology in European countries are driving the growth of the market in the region. For instance, in September 2022, the health ministers and representatives from WHO, Europe’s 53 member states adopted the region’s first digital health action strategy, an ambitious plan that will influence the digital revolution in central Asia and Europe with the goal of improving people’s health and well-being.
By Application
By Delivery
By End-Use
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Acute Care Telemedicine Market
5.1. COVID-19 Landscape: Acute Care Telemedicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Acute Care Telemedicine Market, By Delivery
8.1. Acute Care Telemedicine Market, by Delivery, 2024-2033
8.1.1 Clinician-to-patient
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Clinician-to-clinician
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Acute Care Telemedicine Market, By Application
9.1. Acute Care Telemedicine Market, by Application, 2024-2033
9.1.1. Teleradiology
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Telepsychiatry
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. TeleICU
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Teleneurology
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Telenephrology
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Acute Care Telemedicine Market, By End-use
10.1. Acute Care Telemedicine Market, by End-use, 2024-2033
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Others
10.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Acute Care Telemedicine Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.1.2. Market Revenue and Forecast, by Application (2021-2033)
11.1.3. Market Revenue and Forecast, by End-use (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.1.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.1.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.2.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.3.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.5.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Delivery (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.5.5.3. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 12. Company Profiles
12.1. ScienceSoft USA Corporation.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AMN Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Orbit Health GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. US Acute Care Solutions, LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. SOC Telemed
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. SynergenX
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Eagle Telemedicine.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Vidyo, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. RelyMD.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms